JOHNSON & JOHNSON (JNJ) Liabilities and Equity USD 2009 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Johnson & Johnson quarterly Liabilities and Equity history and growth rate from 2009 to 2024.
  • Johnson & Johnson Liabilities and Equity for the quarter ending March 31, 2024 was $172B, a 12.2% decline year-over-year.
Liabilities and Equity, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $172B -$24B -12.2% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $168B -$19.8B -10.6% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $166B -$9.06B -5.18% Oct 1, 2023 10-Q 2023-10-27
Q2 2023 $192B +$14B +7.86% Jul 2, 2023 10-Q 2023-07-31
Q1 2023 $196B +$17.6B +9.88% Apr 2, 2023 10-Q 2023-04-28
Q4 2022 $187B +$5.36B +2.95% Jan 1, 2023 10-K 2024-02-16
Q3 2022 $175B -$4.1B -2.29% Oct 2, 2022 10-Q 2022-10-27
Q2 2022 $178B +$1.28B +0.73% Jul 3, 2022 10-Q 2022-07-29
Q1 2022 $178B +$5.8B +3.36% Apr 3, 2022 10-Q 2022-04-29
Q4 2021 $182B +$7.12B +4.07% Jan 2, 2022 10-K 2023-02-16
Q3 2021 $179B +$8.54B +5% Oct 3, 2021 10-Q 2021-10-29
Q2 2021 $176B +$18.1B +11.4% Jul 4, 2021 10-Q 2021-07-29
Q1 2021 $173B +$17.5B +11.3% Apr 4, 2021 10-Q 2021-04-30
Q4 2020 $175B +$17.2B +10.9% Jan 3, 2021 10-K 2022-02-17
Q3 2020 $171B +$15.2B +9.76% Sep 27, 2020 10-Q 2020-10-23
Q2 2020 $158B +$3.26B +2.1% Jun 28, 2020 10-Q 2020-07-24
Q1 2020 $155B +$4.99B +3.33% Mar 29, 2020 10-Q 2020-04-29
Q4 2019 $158B +$4.77B +3.12% Dec 29, 2019 10-K 2021-02-22
Q3 2019 $156B -$182M -0.12% Sep 29, 2019 10-Q 2019-10-28
Q2 2019 $155B -$248M -0.16% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $150B -$6.6B -4.21% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $153B -$4.35B -2.77% Dec 30, 2018 10-K 2020-02-18
Q3 2018 $156B +$45M +0.03% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $155B +$2.56B +1.67% Jul 1, 2018 10-Q 2018-08-02
Q1 2018 $157B +$11.7B +8.08% Apr 1, 2018 10-Q 2018-05-01
Q4 2017 $157B +$16.1B +11.4% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $156B +$15.3B +10.9% Oct 1, 2017 10-Q 2017-11-02
Q2 2017 $153B +$13B +9.29% Jul 2, 2017 10-Q 2017-08-03
Q1 2017 $145B +$8.69B +6.38% Apr 2, 2017 10-Q 2017-05-08
Q4 2016 $141B +$7.8B +5.84% Jan 1, 2017 10-K 2018-02-21
Q3 2016 $140B +$7.1B +5.33% Oct 2, 2016 10-Q 2016-11-04
Q2 2016 $140B +$7.78B +5.89% Jul 3, 2016 10-Q 2016-08-04
Q1 2016 $136B +$7.64B +5.94% Apr 3, 2016 10-Q 2016-05-10
Q4 2015 $133B +$3.05B +2.34% Jan 3, 2016 10-K 2017-02-27
Q3 2015 $133B +$1.17B +0.89% Sep 27, 2015 10-Q 2015-10-30
Q2 2015 $132B -$3.16B -2.34% Jun 28, 2015 10-Q 2015-07-31
Q1 2015 $129B -$4.74B -3.56% Mar 29, 2015 10-Q 2015-05-01
Q4 2014 $130B -$2.33B -1.75% Dec 28, 2014 10-K 2016-02-24
Q3 2014 $132B +$5.16B +4.07% Sep 28, 2014 10-Q 2014-10-30
Q2 2014 $135B +$10.9B +8.75% Jun 29, 2014 10-Q 2014-08-01
Q1 2014 $133B +$11.8B +9.7% Mar 30, 2014 10-Q 2014-05-02
Q4 2013 $133B +$11.3B +9.34% Dec 29, 2013 10-K 2015-02-24
Q3 2013 $127B +$7.98B +6.71% Sep 29, 2013 10-Q 2013-11-04
Q2 2013 $124B +$8.58B +7.41% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $122B +$5.34B +4.6% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $121B +$7.7B +6.78% Dec 30, 2012 10-K 2014-02-21
Q3 2012 $119B +$7.13B +6.38% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $116B +$3.64B +3.24% Jul 1, 2012 10-Q 2012-08-02
Q1 2012 $116B +$8.04B +7.44% Apr 1, 2012 10-Q 2012-05-07
Q4 2011 $114B +$10.7B +10.4% Jan 1, 2012 10-K 2013-02-22
Q3 2011 $112B +$13.6B +13.8% Oct 2, 2011 10-Q 2011-11-08
Q2 2011 $112B +$19.8B +21.5% Jul 3, 2011 10-Q 2011-08-09
Q1 2011 $108B +$14.7B +15.7% Apr 3, 2011 10-Q 2011-05-10
Q4 2010 $103B +$8.23B +8.69% Jan 2, 2011 10-K 2012-02-23
Q3 2010 $98.2B Oct 3, 2010 10-Q 2010-11-10
Q2 2010 $92.3B Jul 4, 2010 10-Q 2010-08-11
Q1 2010 $93.4B Apr 4, 2010 10-Q 2010-05-10
Q4 2009 $94.7B Jan 3, 2010 10-K 2011-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.